Form 4: Myriad Genetics COO Samraat S. Raha Reports Acquisition and Disposal of Common Stock
SEC Form 4 Filing
Chief Operating Officer of Myriad Genetics, Samraat S. Raha, reports acquiring and disposing of common stock and holding 300,854 shares following the transaction.
Summary
- On March 14, 2024, Samraat S. Raha, the Chief Operating Officer of Myriad Genetics Inc., reported a transaction involving the company's common stock.
- Raha acquired 64,494 shares of common stock at $0.
- Raha disposed of common stock.
- Following the reported transaction, Raha beneficially owns 300,854 shares of Myriad Genetics Inc.
- The acquisition involved time-based restricted stock units granted under the company's 2017 Employee, Director and Consultant Equity Incentive Plan, vesting in three equal annual installments starting one year from the grant date.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing, indicating neutral sentiment.
Industry Context
This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies.
Stakeholder Impact
- The transaction may have a minor impact on shareholder sentiment, reflecting executive compensation and alignment with company performance.
Key Dates
| Date | Description |
|---|---|
| 03/14/2024 | Date of transaction involving Myriad Genetics common stock. |
| 03/18/2024 | Date of signature for the report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.